Greenwich Lifesciences, Inc. [GLSI]

Source: 

Company Overview

Greenwich Lifesciences, Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrencesin patients who have previously undergone surgery.